SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-24-162669
Filing Date
2024-06-17
Accepted
2024-06-17 16:53:30
Documents
15
Period of Report
2024-06-11
Items
Item 3.03: Material Modifications to Rights of Security Holders
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 5.07: Submission of Matters to a Vote of Security Holders
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d775079d8k.htm   iXBRL 8-K 35941
2 EX-3.1 d775079dex31.htm EX-3.1 9570
3 EX-3.2 d775079dex32.htm EX-3.2 171305
  Complete submission text file 0001193125-24-162669.txt   387988

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA bvs-20240611.xsd EX-101.SCH 2854
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE bvs-20240611_lab.xml EX-101.LAB 19483
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE bvs-20240611_pre.xml EX-101.PRE 12157
18 EXTRACTED XBRL INSTANCE DOCUMENT d775079d8k_htm.xml XML 3977
Mailing Address 4721 EMPEROR BOULEVARD, SUITE 100 DURHAM NC 27703
Business Address 4721 EMPEROR BOULEVARD, SUITE 100 DURHAM NC 27703 (919) 474-6700
Bioventus Inc. (Filer) CIK: 0001665988 (see all company filings)

IRS No.: 810980861 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37844 | Film No.: 241049006
SIC: 3841 Surgical & Medical Instruments & Apparatus
(CF Office: 08 Industrial Applications and Services)